RC
STJ

Riversville Capital’s St Jude Medical STJ Stock Holding History

Riversville Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,755
Closed -$480K – 108
2013
Q4 		$480K Buy
7,755
+173
+2% +$10K 0.27% 79
2013
Q3 		$407K Hold
7,582
– – 0.22% 87
2013
Q2 		$346K Buy
+7,582
New +$329K 0.2% 88

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Riversville Capital's STJ Position: Q1 2014 in Review

Riversville Capital sold out of St Jude Medical (STJ) in Q1 2014, closing a stake of 7,755 shares — an estimated $480K sold.

Riversville Capital first reported a position in STJ in Q2 2013 and held it in 3 quarters. The position peaked at $480K in Q4 2013. 565 funds tracked by Wall St. Rank hold STJ as of Q1 2014.

  • Riversville Capital reported no remaining St Jude Medical position as of Q1 2014 after selling out during the quarter.
  • Riversville Capital sold 7,755 St Jude Medical shares in Q1 2014, an estimated $480K.
  • Riversville Capital first reported a position in St Jude Medical in Q2 2013 and held it in 3 quarters.
  • Riversville Capital's St Jude Medical position peaked at $480K in Q4 2013.
  • 565 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2014.

Based on Riversville Capital's 13F filing for Q1 2014, filed 10 Apr 2014.